효소처리 타나까 추출물을 함유하는 조성물
    72.
    发明公开
    효소처리 타나까 추출물을 함유하는 조성물 审中-实审
    含有精制THANAKHA提取物的组合物

    公开(公告)号:KR1020140117168A

    公开(公告)日:2014-10-07

    申请号:KR1020130032264

    申请日:2013-03-26

    CPC classification number: A61K8/97 A61K36/75 A61K2236/00 A61Q19/02 A61Q19/08

    Abstract: The present invention relates to a composition including thanakha extracts processed with an enzyme. Specifically, provided is usage of anti-aging, antioxidant, skin whitening, etc. effects of the thanakha extract. More specifically, provided in the present invention is a composition for lifting wrinkles or inhibiting or preventing the same, promoting skin elasticity, anti-aging, antioxidant and skin whitening effects including thanakha extracts processed with enzyme as an active ingredient.The thanakha extracts processed with enzyme is characterized by having an excellent antioxidant effect.

    Abstract translation: 本发明涉及一种组合物,其包含用酶处理的不同的提取物。 具体来说,提供了抗酸,抗氧化,皮肤美白等的用途。 更具体地说,本发明提供了一种用于提升皱纹或抑制或防止皱纹的组合物,促进皮肤弹性,抗衰老,抗氧化和皮肤美白效果,包括用酶作为活性成分处理的胡萝卜提取物。 酶的特征在于具有优异的抗氧化作用。

    카나비노이드 1 수용체 저해제로 작용하는 신규 화합물
    73.
    发明公开
    카나비노이드 1 수용체 저해제로 작용하는 신규 화합물 审中-实审
    新型化合物作为CANNABINOID受体-1抑制剂

    公开(公告)号:KR1020130099930A

    公开(公告)日:2013-09-06

    申请号:KR1020137005744

    申请日:2011-08-31

    CPC classification number: C07D487/04 A61K31/519

    Abstract: PURPOSE: A novel compound is provided to prevent or treat diseases mediated by a cannabinoid 1 receptor. CONSTITUTION: A compound of chemical formula 1 or a prodrug, an isomer, a pharmaceutically acceptable salt, a hydrate, or a solvate thereof is provided. A pharmaceutical composition contains the compound of chemical formula 1, the prodrug, the isomer, the pharmaceutically acceptable salt, the hydrate, or the solvate thereof. The pharmaceutical composition is used for preventing or treating diseases mediated by cannabinoid 1 receptor. The diseases medicated by cannabinoid 1 receptor are obesity.

    Abstract translation: 目的:提供一种新型化合物,用于预防或治疗由大麻素1受体介导的疾病。 构成:提供化学式1化合物或其前体药物,异构体,药学上可接受的盐,水合物或溶剂合物。 药物组合物含有化学式1的化合物,前药,异构体,药学上可接受的盐,水合物或其溶剂化物。 药物组合物用于预防或治疗由大麻素1受体介导的疾病。 由大麻素1受体引起的疾病是肥胖。

    피부 미백용 조성물
    74.
    发明公开
    피부 미백용 조성물 审中-实审
    皮肤白化成分

    公开(公告)号:KR1020130043889A

    公开(公告)日:2013-05-02

    申请号:KR1020110108051

    申请日:2011-10-21

    Abstract: PURPOSE: A composition for skin whitening is provided to show pigmentation suppression, and to have an excellent skin whitening effect by having a deterrent effect on tyrosinase which is an apoenzyme of melanogenesis and by containing an extract of acanthopanax. CONSTITUTION: A composition for skin whitening comprises an enzymatically treated extract of acanthopanax as an active ingredient. Acanthopanax is more than one of species selected from the group of Acanthopanax senticosus, Eleutherococcus senticocus, Acanthopanax senticosus for. Inermis, Acanthopanax sessilitlorus, Eleutherococcus divaricatus var. chiisanensis, Acanthopanax seoulense, Eleutherococcus divaricatus, Eleutherococcus gracilistylus, and Acanthopanax siebololianum. An enzyme is a cell wall degrading enzyme or proteinase. The cell wall degrading enzyme comprises cellulose. The proteinase comprises pectinase. The cellulase comprises celluclast. [Reference numerals] (AA) Voltage[mV]; (BB) Time(minutes)

    Abstract translation: 目的:提供用于皮肤美白的组合物,以显示色素沉着抑制,并且通过对作为黑素生成的脱辅基酶的酪氨酸酶具有阻止作用并且含有刺五加的提取物具有优异的皮肤美白效果。 构成:用于皮肤美白的组合物包含酶处理的刺五加的提取物作为活性成分。 刺五加是从刺五加,Eleutherococcus senticocus,Acanthopanax senticosus中选出的一种以上的物种。 Inermis,Acanthopanax sessilitlorus,Eleutherococcus divaricatus var。 刺五加,刺五加,Eleutherococcus divaricatus,Eleutherococcus gracilistylus和Acanthopanax siebololianum。 酶是细胞壁降解酶或蛋白酶。 细胞壁降解酶包括纤维素。 蛋白酶包括果胶酶。 纤维素酶包括celluclast。 (标号)(AA)电压[mV]; (BB)时间(分钟)

    물푸레나무 추출물의 발효물을 포함하는 피부 미백용 조성물
    75.
    发明公开
    물푸레나무 추출물의 발효물을 포함하는 피부 미백용 조성물 无效
    用于皮肤刺激的组合物,用于生产FRAXINUS RHYNCHOPHYLLA HANCE的发酵提取物

    公开(公告)号:KR1020130003171A

    公开(公告)日:2013-01-09

    申请号:KR1020110064294

    申请日:2011-06-30

    Abstract: PURPOSE: A composition containing a fermentation of a Fraxinus rhynchophylla Hance extract is provided to suppress tyrosinase activation and melanogenesis and to ensure excellent skin whitening effect. CONSTITUTION: A composition for skin whitening contains 0.001-20 wt% of a fermentation of a Fraxinus rhynchophylla Hance as an active ingredient. The extract is prepared using water, an organic solvent, or a mixture thereof. The fermentation is preparing by fermenting the extract with yeast such as Saccaromyces sp., Schizosaccharomyces sp., Torulopsis sp., Rhodotorula sp., or Candida ap. The composition is a cosmetic or pharmaceutical composition.

    Abstract translation: 目的:提供含有Fraxinus rhynchophylla Hance提取物发酵的组合物,以抑制酪氨酸酶活化和黑素生成,并确保优异的皮肤美白效果。 构成:用于皮肤美白的组合物含有作为活性成分的Fraxinus rhynchophylla Hance的发酵量的0.001-20重量%。 提取物是用水,有机溶剂或其混合物制备的。 发酵是通过用酵母如Saccaromyces sp。,粟酒裂殖酵母属(Saccharomyces sp。),Torulopsis sp。,红酵母属(Rhodotorula sp。)或假丝酵母(Candida ap)发酵提取物制备的。 组合物是化妆品或药物组合物。

    이소플라본 및 이카리시드 B2를 함유하는 항노화용 피부 외용제 조성물
    80.
    发明公开
    이소플라본 및 이카리시드 B2를 함유하는 항노화용 피부 외용제 조성물 审中-实审
    皮肤外用组合物,用于抗衰老,含有异佛尔酮

    公开(公告)号:KR1020160082127A

    公开(公告)日:2016-07-08

    申请号:KR1020140194618

    申请日:2014-12-31

    Abstract: 본발명은이소플라본및 이카리시드 B2를함유하는항노화용피부외용제조성물에관한것으로, 보다구체적으로는이소플라본및 이카리시드 B2의시너지효과를이용한항산화용, 콜라겐합성촉진용, 피부탄력개선용, 피부주름개선용피부외용제조성물에관한것이다. 본발명에따른피부외용제조성물은저농도의이소플라본및 이카리시드 B2를최적의함량비로함유함으로써, 항노화효과가우수하고, 진피에서콜라겐생합성을증가시켜주름개선및 탄력회복효과를나타낸다.

    Abstract translation: 本发明涉及一种抗衰老皮肤组合物,其包含用于外用的异黄酮和阿魏酸B2。 更具体地说,本发明涉及使用异黄酮和阿魏酸B2对抗氧化,促进胶原合成,减轻皮肤弹性和减轻皮肤皱纹的协同作用的皮肤组合物。 根据本发明的用于外用的皮肤组合物含有具有光学含量比的低浓度的异黄酮和阿魏酸B2,并且通过增加真皮中的胶原蛋白的生物合成,显示出减轻皮肤皱纹和恢复皮肤弹性的作用。

Patent Agency Ranking